Judith Fraussen
't Hasselt, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38+, CTLA-4+, and PD-1+ T and NK Cells.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 28, 2026
Enhanced MIF/CD74 axis activity shapes B cell functioning following traumatic spinal cord injury.
Journal: Journal of neuroinflammation
Published: January 09, 2026
Spinal cord reactive-antibodies identified by serological antigen selection show prognostic value in traumatic spinal cord injury patients.
Journal: Neurobiology of disease
Published: December 19, 2025
Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohort.
Journal: RMD open
Published: September 30, 2025
Higher humoral response in ileal versus colonic Crohn's disease.
Journal: Clinical and experimental immunology
Published: March 14, 2025
Peripheral immune reactions following human traumatic spinal cord injury: the interplay of immune activation and suppression.
Journal: Frontiers in immunology
Published: September 13, 2024
The macrophage migration inhibitory factor/CD74 axis in traumatic spinal cord injury: lessons learned from animal and human studies.
Journal: European journal of immunology
Published: June 27, 2024
Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 18, 2023
Longitudinal Plasma Biomarker Profiles Predict Neurological Outcome in Traumatic Spinal Cord Injury.
Longitudinal Plasma Biomarker Profiles Predict Neurological Outcome in Traumatic Spinal Cord Injury.
Journal: Annals of neurology
Published: June 20, 2023
IgD-CD27- double negative (DN) B cells: Origins and functions in health and disease.
Journal: Immunology letters
Published: January 06, 2023
Last Updated: 09/26/2026